# Pregabalin and Orofacial Neuropathic Pain

> **NCT00852436** · PHASE2 · TERMINATED · sponsor: **University of Toronto** · enrollment: 1 (actual)

## Conditions studied

- Neuropathic Pain
- Orofacial Pain

## Interventions

- **DRUG:** pregabalin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00852436
- **Lead sponsor:** University of Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-02
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** difficulty to recruit patients
- **Last updated:** 2015-06-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00852436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00852436, "Pregabalin and Orofacial Neuropathic Pain". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00852436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*